Socio Today
Congenital Heart Disease (CHD), known locally as Penyakit Jantung Bawaan (PJB), remains one of the most significant challenges to neonatal health in Indonesia. While the precise etiology of many heart defects remains elusive to the global medical community, health experts emphasize that identifying and mitigating specific risk factors during pregnancy is paramount to reducing the incidence of these conditions. According to Dr. Rizky Adriansyah, a pediatric specialist and the Chairman of the Cardiology Coordination Unit of the Indonesian Pediatric Society (IDAI), the complexity of fetal development means that while direct cause-and-effect relationships are difficult to establish, certain environmental and physiological triggers are consistently linked to the development of heart defects.
The prevalence of CHD in Indonesia reflects a broader global health concern. Data from the World Health Organization (WHO) indicates that approximately one out of every 100 newborns is diagnosed with a congenital heart defect. Of these cases, an estimated 25 percent are classified as "critical CHD," a condition that requires immediate surgical intervention or catheter-based treatment within the first year—and often the first days—of life. In the Indonesian context, the stakes are particularly high. Statistics from 2017 reveal that CHD is the second leading cause of neonatal mortality in the country, accounting for 17 percent of deaths in newborns, surpassed only by complications arising from prematurity.
Understanding the Primary Risk Factors During Pregnancy
Medical literature has recently converged on several key risk factors that significantly increase the probability of a child being born with a heart defect. Dr. Rizky highlights three primary areas of concern that demand the attention of expectant mothers and healthcare providers: maternal infections, nutritional deficiencies, and the consumption of specific medications.
The first major factor is the presence of infections during pregnancy, most notably the Rubella virus, also known as German Measles. When a pregnant woman contracts Rubella, particularly during the first trimester when the fetal heart is forming, the virus can interfere with organogenesis, leading to a cluster of birth defects known as Congenital Rubella Syndrome (CRS). Heart defects, such as patent ductus arteriosus (PDA) and pulmonary artery stenosis, are common manifestations of this syndrome.
The second factor is the deficiency of folic acid (Vitamin B9). Folic acid is essential for DNA synthesis and cell division. While its role in preventing neural tube defects like spina bifida is well-documented, emerging research and clinical observations increasingly link adequate folic acid intake to proper cardiac development. In many developing regions, including parts of Indonesia, maternal malnutrition remains a hurdle, making the supplementation of folic acid a critical public health intervention.
The third highlighted risk factor involves the maternal use of certain medications. Specifically, anti-seizure medications (anticonvulsants) have been identified as potentially teratogenic, meaning they can interfere with the development of an embryo. While women with chronic conditions such as epilepsy must manage their health, medical professionals stress the importance of pre-conception counseling to adjust dosages or switch to safer alternatives under strict supervision.
Beyond these three, historical data has long pointed to maternal smoking and alcohol consumption as risk factors. However, Dr. Rizky notes a complicating reality in clinical practice: many cases of CHD occur in children whose mothers did not smoke or consume alcohol. This suggests that the interplay of genetics and environment is highly nuanced, reinforcing the need for universal screening rather than focusing only on "high-risk" pregnancies.
The Critical Timeline of Fetal Cardiac Development
To understand why prevention must occur early, it is necessary to examine the chronology of human gestation. The human heart is the first functional organ to develop. The process begins as early as the third week of pregnancy, and by the eighth week, the basic structure of the heart—including its four chambers and major vessels—is largely complete.
Because the heart forms so early, many structural defects are already present before a woman may even realize she is pregnant or before her first prenatal visit. This "critical window" is why the IDAI and other health organizations advocate for pre-conception health. Once a child is born with a structural heart defect, the window for primary prevention has closed; the focus must then shift entirely to early detection, stabilization, and surgical correction.
Challenges in Diagnosis and the "Silent" Crisis in Indonesia
Despite the high prevalence of CHD, the diagnostic rate in Indonesia remains alarmingly low. Dr. Rizky Adriansyah points out that fewer than 50 percent of CHD cases in the country are currently being handled or treated effectively. This gap between the number of affected infants and the number of those receiving care is the result of a multifaceted crisis involving infrastructure, human resources, and public awareness.
One of the primary barriers is the geographical distribution of specialized care. Indonesia’s archipelagic geography means that high-tech diagnostic tools, such as pediatric echocardiography, and specialized surgeons are often concentrated in major urban centers on the island of Java. Families in remote provinces often face prohibitive travel costs and logistical hurdles to access life-saving care.
Furthermore, there is a shortage of pediatric cardiologists and cardiovascular surgeons relative to the population. This shortage leads to long waiting lists for surgeries, during which time a child’s condition may deteriorate from "operable" to "inoperable" due to secondary complications like pulmonary hypertension.
Innovations in Early Detection: The Role of Pulse Oximetry
In response to these challenges, medical experts are advocating for the adoption of simpler, more cost-effective screening methods that can be implemented at the primary care level. While echocardiography remains the "gold standard" for diagnosing specific heart defects, it requires expensive machinery and specialized training to interpret.
A more accessible alternative is pulse oximetry screening. This non-invasive test measures the oxygen saturation level in a newborn’s blood. By placing sensors on the baby’s right hand and either foot, healthcare providers can detect "silent" hypoxemia—low oxygen levels that might not be visible to the naked eye as cyanosis (bluish skin).
Pulse oximetry is highly sensitive, fast, and relatively inexpensive. Dr. Rizky emphasizes that this screening should ideally be performed 24 to 48 hours after birth. If a significant difference in oxygen saturation is detected between the hand and the foot, or if the overall saturation is low, it serves as a "red flag" for critical CHD, prompting immediate referral to a specialist.
In addition to technology, the traditional stethoscope remains a vital tool. The detection of a heart murmur—an unusual sound between heartbeats—by a midwife or general practitioner is often the first clue that a child needs a cardiac evaluation. However, experts warn that not all murmurs are pathological, and conversely, some of the most serious heart defects do not produce a loud murmur, which is why pulse oximetry is a necessary secondary screen.
Clinical Symptoms and Parental Vigilance
For children who are not diagnosed in the delivery room, parents must be educated on the subtle signs of heart distress. One of the most common clinical symptoms of CHD in infants is poor weight gain or "failure to thrive." Because a struggling heart requires more energy, the infant may become exhausted during feeding, leading to inadequate caloric intake and slow physical development.
In more severe or critical cases, symptoms appear rapidly within the first week of life. These may include rapid breathing, excessive sweating (especially during feeding), and a bluish tint to the lips or fingernails. Dr. Rizky notes that for critical CHD, the window for intervention is incredibly narrow, often requiring action within the first 24 to 48 hours to prevent organ failure or death.
The Path Forward: Education and Policy Integration
To address the high mortality rates associated with CHD, the Indonesian healthcare system is moving toward a more integrated approach. Education is a cornerstone of this strategy. The IDAI has supported initiatives like the "Sehatkan Jantung Anak Indonesia" (Healthy Hearts for Indonesian Children) YouTube channel, which provides accessible information for both parents and healthcare workers on how to conduct basic screenings and recognize symptoms.
There is also a growing push to empower midwives and nurses in rural areas. Since midwives attend a significant portion of births in Indonesia, training them to perform pulse oximetry and recognize the early signs of cardiac distress could drastically improve the referral pipeline. Dr. Rizky suggests that these screenings take less than five minutes but can mean the difference between life and death.
From a policy perspective, the implications are clear: the Indonesian government and Ministry of Health must continue to prioritize maternal immunization programs, specifically the MR (Measles and Rubella) vaccine, to eliminate Rubella-related heart defects. Additionally, ensuring that folic acid supplementation is a standard part of prenatal care across all socio-economic levels is essential.
In conclusion, while the causes of congenital heart disease may be complex and often idiopathic, the path to reducing its impact is well-defined. Through a combination of maternal vaccinations, proper prenatal nutrition, universal newborn screening using pulse oximetry, and the expansion of specialized pediatric cardiac services, Indonesia can begin to close the gap in care. The goal is not only to increase the survival rate of these "warrior" children but to ensure they have the opportunity to lead healthy, productive lives. As medical professionals and the public become more vigilant, the 17 percent mortality rate attributed to CHD can be significantly diminished, marking a new era for neonatal health in the nation.
